CRT 2024
Innovation
Renal Denervation and Hypertension Therapies [Non-CME]
Brian Fulton, MD
Fellow, Interventional Cardiology
Penn Medicine
Philadelphia, Pennsylvania, United States
Disclosure(s): No financial relationships to disclose
Daniel Burkhoff, MD, PhD
Director: Heart Failure, Hemodynamics and MCS Research
Cardiovascular Research Foundation
New York, New York, United States
Disclosure information not submitted.
Vasilios Papademetriou, MD, DSc
Director Interventional Hypertension and Vascular Medicine
Georgetown University/VAMC
Washington, District of Columbia, United States
No relationships to disclose
Herbert D. Aronow, MD, MPH
Medical Director, Heart & Vascular Services
Henry Ford Health
Detroit, Michigan, United States
No relationships to disclose
Aloke V. Finn, MD
Medical Director CVPath/Assoc. Prof. Of Medicine University of Maryland
CVPath
Gaithersburg, Maryland, United States
No relationships to disclose
David E. Kandzari, MD, FACC, FSCAI
Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure information not submitted.
Michael S. Lee, MD, FACC, FSCAI
Interventional Cardiologist
Southern California Hospital
LOS ANGELES, California, United States
No relationships to disclose
Felix Mahfoud, MD
Professor
Saarland University Hospital
Homburg/Saar, Saarland, Germany
No relationships to disclose
Eric A. Secemsky, MD, MSc
Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure information not submitted.